CG Oncology CGON Redeemable Preferred Stock Dividends
Redeemable Preferred Stock Dividends at other companies
Other financials
Where this comes from
Reported directly by CG Oncology in its filing.
Tagged under the XBRL concept us-gaap:RedeemablePreferredStockDividends.
The official record: CG Oncology’s 10-K, filed February 27, 2026, on SEC EDGAR. View the filing →
Ask your AI about CG Oncology's redeemable preferred stock dividends.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CG Oncology's redeemable preferred stock dividends?
- CG Oncology (CGON) reported redeemable preferred stock dividends of $0 in Q4 2025.
- What is the long-term trend for CG Oncology's redeemable preferred stock dividends?
- Over 2 years (2023 to 2025), CG Oncology's redeemable preferred stock dividends has grown at a -100.0% compound annual growth rate (CAGR), from $18.78M to $0.
- What does redeemable preferred stock dividends mean?
- This represents the periodic dividend payments or accruals associated with preferred equity instruments that are subject to mandatory redemption or redemption at the option of the holder. These payments reflect the cost of capital associated with specific financing structures that prioritize certain shareholders over common equity holders. Analyzing this metric is essential for understanding the company's capital structure and potential future cash obligations to preferred shareholders.